A National Cancer Institute-designated Comprehensive Cancer Center

Make an appointment: 800-826-HOPE

Translational Research Laboratory

Translational Research Laboratory
The Translational Research Laboratory (TRL) at City of Hope is under the direct supervision of Yen Yun, M.D., Ph.D., Associate Director for Translational Research, City of Hope Comprehensive Cancer Center and, Professor and Chair of the Department ofMolecular Pharmacology.
 
The mission of the Translational Research Laboratory (TRL) Core is to facilitate, implement, and support the needs of basic science researchers, clinical researchers, population researchers and clinical science collaborations. Interactions between basic scientists and clinicians are fostered to ensure the inclusion of scientifically sound correlative studies in clinical trials, and also to enable and assist research studies using clinical samples from patients enrolled in clinical trials. Emphasis is placed on the pursuit of institutional collaborations, allowing TRL to integrate with other Core laboratories to work closely together.
 
The following will be offered:
 
  • Pre-clinical studies on experimental drug therapies
     
  • Cell proliferation assay and drug cytotoxicity analysis
  • DNA and RNA isolation and quantification
  • Design and optimization of real-time PCR analysis
  • Protein isolation, western blot, and multiplex ELISA assay
 
  • Bio-specimen repository of clinical and population research protocol samples
 
  • Receiving, processing and storing human samples
  • Database management system to centralize information
 
  • General molecular genetic tests and special assays
  • KRAS mutations in colon cancer
  • EGFR mutations and ALK translations in lung cancer
  • P53 mutations in breast cancer
  • NRAS mutations in pancreatic cancer
  • VLH mutations in kidney cancer
 
  • PTEN mutations in brain cancer Circulating Tumor Cell (CTC) enumeration, enrichment and characterization
 

Pricing

Prices and availability vary. PleaseContact Usfor current information.
 
If you are a City of Hope employee, please click here for pricing.

 

 

Translational Research Team

Research Shared Services

City of Hope embodies the spirit of scientific collaboration by sharing services and core facilities with colleagues here and around the world.
 

Recognized nationwide for its innovative biomedical research, City of Hope's Beckman Research Institute is home to some of the most tenacious and creative minds in science.
City of Hope is one of only 41 Comprehensive Cancer Centers in the country, the highest designation awarded by the National Cancer Institute to institutions that lead the way in cancer research, treatment, prevention and professional education.
Learn more about City of Hope's institutional distinctions, breakthrough innovations and collaborations.
Support Our Research
By giving to City of Hope, you support breakthrough discoveries in laboratory research that translate into lifesaving treatments for patients with cancer and other serious diseases.
 
 
 
 
Media Inquiries/Social Media

For media inquiries contact:

Dominique Grignetti
800-888-5323
dgrignetti@coh.org

 

For sponsorships inquiries please contact:

Stefanie Sprester
213-241-7160
ssprester@coh.org

Christine Nassr
213-241-7112
cnassr@coh.org

 
CONNECT WITH US
Facebook  Twitter  YouTube  Blog
 
NEWS & UPDATES
  • Christine Crews isn’t only a fitness enthusiast, she’s also a personal trainer and fitness instructor. Being active defines her life. So when she was diagnosed with bladder cancer at age 30, she decided she absolutely couldn’t let the disease interfere with that lifestyle. And it didn’t. For t...
  • Cancer treatment and the cancer itself can cause changes in your sense of taste or smell. These side effects typically subside after treatment ends, but there are ways to help alleviate those bitter and metallic tastes in your mouth. Here are tips from the National Cancer Institute to help keeps tastes and food...
  • Immunotherapy — using one’s immune system to treat a disease — has been long lauded as the “magic bullet” of cancer treatments, one that can be more effective than the conventional therapies of surgery, radiation or chemotherapy. One specific type of immunotherapy, called adoptive T cell thera...
  • Today, when cancer spreads from its original site to other parts of the body, a process known as metastasis, patients face an uphill battle. Treatments are poorly effective, and cures are nearly impossible. Further, incidence rates for these types of cancers are increasing – particularly for cancers that have s...
  • Thanks to the California Institute for Regenerative Medicine (CIRM), high school students across the state gained valuable hands-on experience with stem cell research this summer. City of Hope hosted eight of those students. As part of the CIRM Creativity Awards program, the young scholars worked full time as m...
  • Radiation therapy can help cure many children facing Hodgkin lymphoma and other cancers. When the radiation is delivered to a girl’s chest, however, it can lead to a marked increase in breast cancer risk later in life. A recent multi-institutional study that included City of Hope’s Smita Bhatia, M.D., M.P.H., t...
  • A patient diagnosed with cancer – especially a rare, advanced or hard-to-treat cancer – needs specialized care from exceptionally skilled and highly trained experts. That kind of care saves lives, improves quality of life and keeps families whole. That kind of care is best found at comprehensive cancer centers ...
  • Appetite loss may be common during cancer treatment, lasting throughout your therapy or only occasionally, but it can be managed. Below are tips from the National Cancer Institute (NCI) that can help you keep your weight up and, in doing so, keep your body well-nourished. (See the end of this article for a deli...
  • Myelodysplasia, sometimes referred to as myelodysplastic syndrome or MDS, is a rare group of blood disorders caused by disrupted development of blood cells within the bone marrow, resulting in a decreased number of healthy blood cells. People diagnosed with the condition, considered a precancer, may be at great...
  • Twenty years ago, scientists discovered that a mutation in a gene now widely known as BRCA1 was linked to a sharply increased risk of breast cancer, paving the way for a new chapter in identifying women at risk of the disease and giving them options to potentially avoid an aggressive cancer. But experts have al...
  • The Eugene and Ruth Roberts Summer Student Academy at City of Hope turned 54 this year. Marking the occasion, the academy announced a new scholarship in honor of longtime director Paul Salvaterra, Ph.D. Salvaterra, a professor in City of Hope’s Department of Neurosciences, has led the summer student acade...
  • Stevee Rowe has a very personal connection to the research she’s conducting on neural stem cells: Her late father participated in a City of Hope clinical trial involving neural stem cells. Rowe — her full name is Alissa Stevee Rowe, but she prefers to use her middle name — will enter her senior year at the [...
  • Although multiple myeloma is classified as a blood cancer, patients with this disease often experience bone-related symptoms, too. This includes bone pain, frequent fractures and spots of low bone density or bone damage that show up during a skeletal scan. Here, Amrita Krishnan, M.D., director of City of Hope&#...
  • Women using some birth control pills, specifically those with high doses of estrogen and a few other formulations, may be at an increased risk of breast cancer, a new study has found. At first glance, the findings seem alarming, but a City of Hope breast cancer surgeon is warning against overreaction. The study...
  • Cancer is hard enough on the immune system, and chemotherapy takes an additional toll. This double blow to the immune system means cancer patients are more likely to develop infections than people not fighting cancer. The federal Centers for Disease Control and Prevention reports that one out of every 10 cancer...